Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Cephalothin

    • Product Name Cephalothin
    • Alias cef, cefalotin
    • Einecs 200-360-9
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    562382

    Generic Name Cephalothin
    Drug Class First-generation cephalosporin antibiotic
    Chemical Formula C16H16N2O6S2
    Molecular Weight 396.44 g/mol
    Route Of Administration Intravenous, Intramuscular
    Mechanism Of Action Inhibits bacterial cell wall synthesis
    Spectrum Of Activity Gram-positive bacteria, some gram-negative bacteria
    Indications Bacterial infections such as respiratory tract, urinary tract, skin, and bone infections
    Half Life Approximately 0.5 to 1 hour
    Protein Binding 65-80%
    Metabolism Hepatic
    Elimination Primarily renal

    As an accredited Cephalothin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging for Cephalothin includes a sterile glass vial containing 1 gram of white crystalline powder, labeled with dosage and storage instructions.
    Shipping Cephalothin should be shipped in tightly sealed containers, protected from light and moisture. Transport must comply with regulations for pharmaceutical chemicals, including proper labeling and documentation. It should be kept at a controlled room temperature and handled with care to avoid breakage or contamination during transit. Use secondary containment for spill prevention.
    Storage Cephalothin should be stored in a tightly closed container at a temperature between 2°C and 8°C (36°F–46°F), and protected from light and moisture. Avoid freezing. Keep it away from incompatible substances, such as strong oxidizers. Proper storage conditions help maintain the drug’s stability and effectiveness, and ensure the safety of personnel handling the chemical.
    Application of Cephalothin

    Applications of Cephalothin in Industrial Manufacturing

    As a direct manufacturer of high-quality Cephalothin, we supply bulk volumes of this first-generation cephalosporin for strict pharmaceutical formulations and sterile production lines. The downstream applications described below highlight the main industrial integration tracks, reflecting current regulatory environments and our ongoing engagement with validated end-use manufacturing facilities worldwide.

    1. Sterile Injectable Antibiotic Formulations for Human Health

    Pharmaceutical companies globally rely on Cephalothin as a primary active pharmaceutical ingredient (API) for manufacturing sterile injectable antibiotics administered by healthcare professionals to treat severe Gram-positive and some Gram-negative bacterial infections. Production facilities handle rigorous aseptic processing, integrating our material following validated sterilization and filtration steps crucial for parenteral safety. Processors must precisely adjust input concentrations based on target vial dosages and stability data from pilot and scale-up batches to meet label claims while controlling for injection-site tolerance and pharmacokinetics.

    Industry compliance standards

    • European Pharmacopoeia (Ph. Eur. Monograph 1093 – Cefalotin sodium)
    • United States Pharmacopeia (USP Monograph – Cefalotin for Injection)
    • Current Good Manufacturing Practice (cGMP) for Finished Pharmaceuticals (FDA 21 CFR 210/211)
    • WHO Prequalification Programme for injectable antibiotics

    Typical usage ratio

    • 95% – 98% by mass of powder fill for single-dose or multi-dose vials; minor components include excipients such as sodium carbonate to stabilize pH and lyophilization bulking agents. Formulators adjust concentration to achieve typical 500 mg, 1 g, or 2 g per vial fill as registered.

    Downstream process integration

    • Introduced post-sterilization, prior to dissolution and final filtration in class 100 cleanrooms before aseptic vial filling and lyophilization or sealing under nitrogen. Closely controlled batch records document every step for lot traceability.

    Final product types

    • Sterile injectable powder vials (human hospital and clinical use)
    • Pre-filled single-use syringes
    • Multi-dose injectable antibiotic vials for emergency/critical care

    2. Veterinary Parenteral Antibiotic Production

    Feedlot operators and animal health pharmaceutical producers depend on Cephalothin as an API for injectable veterinary drugs targeting severe mastitis, metritis, and other infections in cattle and companion animals. Veterinary drug product lines, while drawing on similar primary-sourcing principles as human medicine, face different in-use shelf life and species-specific withdrawal period requirements, closely monitored by agricultural regulators. Formulation engineering focuses on stable injectable forms suitable for field administration by livestock veterinarians.

    Industry compliance standards

    • European Union GMP for Veterinary Medicinal Products (Directive 91/412/EEC)
    • VICH GL18 Stability Testing Guidelines
    • European Pharmacopoeia Monograph 1093
    • US FDA Guidance for Industry #61: 21 CFR 514 (Veterinary Drug Approval)

    Typical usage ratio

    • 92% – 97% of total powder formula per dosage form; balance consists of stabilizers, disintegrants, and carrier bases for rapid reconstitution; actual content specified by intended dose per species—commonly 1–5 g per bottle depending on application schedule and animal weight.

    Downstream process integration

    • Added to formulation tank after pre-dissolution of buffer salts; subject to sterile filtration before aseptic filling into veterinary vials for lyophilization or liquid formats, depending on field-use stability targets.

    Final product types

    • Lyophilized veterinary injection vials
    • Liquid injectable preparations for livestock or pets
    • Bulk powder refill packs for large farm veterinary protocols

    3. Bulk Pharmaceutical Ingredient (BPI) Supply for Formulators and Contract Manufacturers

    Third-party formulation plants and CMO/CDMO facilities purchasing bulk Cephalothin depend on reliable physical attributes and high purity for direct wet granulation, sterile mixing, or as part of custom compounding processes aligned to client IP and market authorizations. As a BPI, our product routinely passes stringent physicochemical and microbiological examination to support batch homogeneity across global fill/finish partners. Downstream traceability documentation aligns with international import and QA protocols.

    Industry compliance standards

    • ICH Q7A Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • TGA (Australia) BP/Ph. Eur. Certificate of Suitability CoS (CEP)
    • China NMPA Drug Master File (DMF) requirements
    • US FDA Drug Master File Type II submissions

    Typical usage ratio

    • 100% pure API supplied for downstream blending, with process-specific blending typically diluting to 93–99% API in final batch dependent on end-formulation requirements dictated by client dossiers or regulatory licenses.

    Downstream process integration

    • Supplied in double-lined sterile drums or bags; opened under controlled conditions, then either blended dry for powder-fill or dissolved under GMP controls for further pharmaceutical compounding and aseptic processing.

    Final product types

    • Bulk sterile intermediate ready for direct vial filling
    • Lyophilization intermediates for custom injectables
    • Plug-and-play input for CMOs producing finished dosage forms on behalf of MAH customers

    4. Compounded Antibiotic Preparations in Hospital Pharmacies

    Designated hospital pharmacy units, often serving infectious disease wards and intensive care settings, use Cephalothin to compound patient-specific or batch-required injectable antibiotic preparations to address urgent shortages or individualized dosing needs. Hospital-based compounding operates under local health authority and national compounding policy scrutiny, working within defined stability and sterility parameters to ensure timely bedside administration.

    Industry compliance standards

    • USP Chapter 797 (Pharmaceutical Compounding – Sterile Preparations)
    • European Union Guidelines on Good Preparation Practice for Hospital Pharmacies
    • Joint Commission Accreditation for Health Systems Compounding

    Typical usage ratio

    • Adjusted to 90–100% Cephalothin by reconstitution mass, enabling pharmacists to rapidly achieve required therapeutic concentrations per patient prescription, based on clinical pharmacokinetics and local microbiology lab guidance.

    Downstream process integration

    • Withdrawn under sterile isolator units from multi-dose hospital-use containers or vials, dissolved in compatible carrier (often sterile saline or water), then dispensed in single- or multi-dose syringes or IV bags for immediate administration under pharmacy batch protocols.

    Final product types

    • Compounded injectable syringes for hospital use
    • Small-scale IV antibiotic drips prepared for urgent dosing
    • Reconstituted antibiotic solutions for inpatient or critical care environments
    Free Quote

    Competitive Cephalothin prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Cephalothin: Experience and Perspective on a Legacy β-Lactam

    Cephalothin: Background and Context

    Decades on the production floor shape one’s understanding of cephalosporins better than any textbook. Cephalothin, as an early-generation cephalosporin, does not grab headlines like newer antibiotics, but it continues to serve an essential function in pharmaceutical manufacturing, research, and veterinary medicine. Our team has produced this compound almost since it first joined the medical landscape. We follow not just regulatory guidelines but a culture of traceability and quality ingrained over countless batches.

    Model and Specifications Gained Through Practice

    Our cephalothin comes primarily as the sodium salt, crystalline, with purity we typically maintain above 98.5% by HPLC. The yellowish-white powder dissolves swiftly in sterile water and offers the stability needed for long-haul shipment. Each lot passes rigorous checks: moisture, heavy metals, residues, and any trace of related substances. Over years of feedback from compounding pharmacies, research labs, and animal health producers, we have adjusted particle size specifications to maximize handling and mixing in real-world environments. We regularly calibrate our sieving and drying equipment to achieve narrow ranges suitable for sterile preparations. Those who formulate injectable solutions or fill vials say batch-to-batch reliability helps them keep their end operations moving without stoppages.

    Why Cephalothin Still Matters

    Many see cephalothin as an old-timer, but we recognize lasting value where newer molecules sometimes falter. Cephalothin demonstrates consistent stability, with straightforward hydrolysis kinetics that let formulation chemists predict behavior in solution. Clinicians and researchers trust it as a reference for susceptibility tests, including CLSI standards. In veterinary medicine, cephalothin remains critical for certain uses, particularly in dairy cows because of its long-established residue profiles in milk and tissue. Farm managers and animal health experts often cite our product’s predictable stability in suspension, which makes farm administration safer and easier to manage.

    Compared to more recent cephalosporins, cephalothin’s spectrum remains reliably focused. Gram-positive pathogens, especially Staphylococcus spp., remain susceptible—a fact that gains new importance where multidrug resistance challenges become routine. User experience confirms that cephalothin’s low irritancy profile reduces localized tissue problems even with repeated parenteral dosing. This observation mirrors what our QC teams see in solubility checks and pH control: the product stays gentle, as intended, lot after lot.

    Practical Learning: Manufacturing Insights

    Years handling raw intermediates and monitoring fermentations bring a deep appreciation for the subtleties behind cephalothin’s synthesis. Chefs have recipes; chemists have sequences, and ours has taken shape through careful calibration. Early in production, the choice of appropriate penicillin intermediates and finely engineered acylation steps set the course for yield and purity. To avoid side products, we keep our reactors at precisely balanced temperatures. This diligence saves hours of downstream separation and re-crystallization that less careful producers must contend with. We do not cut corners on purification—we know that even small process deviations can yield impurities that customers would spot at their benches. Continuous process improvement extends beyond paperwork to hands-on interventions: tuning fermenter agitation speeds, optimizing solvent preparation, and cutting down unnecessary transfers limit contamination risk.

    Our operators observe changes minute by minute using real-time analytics. This direct feedback has helped us reduce batch failures and ensure the sodium salt’s crystalline habit stays consistent for packaging. Each time a client shares end-user feedback, it feeds back into how we select raw materials or validate equipment cleaning protocols. These improvements add up. We hear from distributors and researchers that vials reconstitute without visible particles or extended mixing—this did not always happen before we revised our drying and milling approach a decade ago. Reliable documentation supports user audits and simplifies import into regulated markets.

    Comparison with Other β-Lactams

    Manufacturing cephalothin alongside other cephalosporins like cefazolin, cefalexin, or later generations, we see patterns in chemical reactivity and downstream behaviors. Cephalothin, for instance, handles better under moderate ambient conditions before lyophilization—this allows more flexibility in shipment for finished formulation partners. The sodium salt does not take up moisture as easily as some newer cephalosporins, which translates to fewer stability issues over long journeys.

    Comparing cephalothin with penicillins, it stands apart for better resistance to β-lactamase enzymes from key pathogens. It withstands moderate agitation and stays in solution longer, which veterinary field teams appreciate during mass dosing exercises or when preparing large-volume infusions. Some partners have switched projects back from other cephalosporins to cephalothin after running into precipitation issues or inconsistent dissolution. It does not offer the broader Gram-negative spectrum of recent molecules, but projects requiring that profile use different candidates entirely.

    Handling, Safety, and User Experience

    In real facilities, the details matter. Cephalothin demonstrates low dusting characteristics in handling, which cuts operator exposure risk. Here, engineering controls like glove boxes and local extraction help, but the product’s dense crystal habit makes spills less of a concern than those from lighter powders. Storage stability has improved as we refined excipient and sodium salt coordination—clients storing stock at ambient conditions report negligible degradation within their normal use windows.

    As chemical manufacturers, we pay close attention to lot traceability and shipment protection. We use tamper-evident containers and humidity-controlled packaging rooms to keep cephalothin within material specifications from our warehouse to the final end user. Years ago, some clients reported odd odors or discoloration in extended storage, so we overhauled desiccant protocols and temperature monitoring. Now, complaints like this rarely arise, even after multi-week sea shipments and warehouse delays. Quality tracking extends to drum lining materials: Even trace interactions between packaging and the cephalothin can influence the final product’s characteristics. Field users—especially those preparing injectables—deserve consistency, not surprises.

    Supporting Research and Veterinary Application

    Research labs continue to purchase cephalothin for use as a reference β-lactam. Both antimicrobial studies and enzymatic assays rely on pure, well-characterized starting materials. University labs and diagnostic kit developers share feedback about our lot documentation and batch consistency, which support reproducible results. We maintain certificates of analysis with every shipment and routinely participate in proficiency testing. Our cephalothin frequently appears as a standard in studies examining β-lactamase resistance mechanisms or evaluating cross-resistance patterns in clinical isolates.

    In veterinary practice, cephalothin continues to fill a critical role, especially for mastitis control and surgical prophylaxis in large animals. Veterinarians buy not just on price but on performance and reliability. We learned from practice that inconsistent reconstitution or unexpected sedimentation can cause real headaches in the field. By working closely with formulation partners and veterinarians, we improved our manufacturing granularity; our current material generates fewer complaints about clogging or incomplete dissolution, which reduces wastage and frustration at the farm or clinic.

    Regulatory Considerations and Quality Investments

    Years of experience with global filings taught us that compliance and transparency go hand in hand. We prepare detailed master files and respond rapidly to regulatory agency requests around the world. Traceability starts from our suppliers: We audit raw materials upstream and update testing protocols as requirements evolve. Feedback loops with our quality assurance teams keep records up to date and processes adaptable to changing international standards. End users regularly request batch data to support their filings—our documentation track record secures relationships and smooths revalidation or requalification processes during plant audits.

    Throughout manufacturing, our staff observe for even minor deviations. Spotting variations in color or solubility ensures that any potential out-of-spec behaviour gets resolved before the product leaves our doors. Several regulatory agencies visit regularly; our teams are accustomed to demonstrating process controls, cleaning protocols, and deviation management. These encounters build both trust and a healthy sense of responsibility toward product safety and user confidence.

    Forward Progress and Adaptation

    Antibiotic manufacturing remains a discipline shaped by change. Legal restrictions, emerging resistance trends, and the steady introduction of new molecules keep the landscape dynamic. Yet, cephalothin persists where its characteristics and historical residue profiles offer advantages. Each year, we invest in new analytical equipment, staff training, and process automation. Small gains add up: Advanced particle size analytics sharpen our product specifications; cleaner environmental monitoring reduces contamination events. The effectiveness of these steps can be measured by the decline in product complaints and increase in client reorders.

    Customer needs evolve. Some clients now request smaller vials or pre-filled syringes for farm administration, which prompted us to adjust batch sizes and packaging formats. Others require additional purity metrics or compatibility testing with new excipients. We carry out bespoke studies to support them and ensure cephalothin suits both new delivery systems and traditional compounding needs. These adaptations start with open dialogue and a willingness to revisit old practices in light of real-world evidence.

    Differences from Later Cephalosporins

    A side-by-side look at cephalothin versus later cephalosporins shows value in specialization over generalization. Where later generations chase broader spectra and oral bioavailability, cephalothin stays valued for parenteral administration, narrow Gram-positive activity, and established safety records in production animals. Ease of handling, robust stability, and long-standing residue profiles matter in regulatory clearance, particularly for food-producing animals.

    Production teams face less concern over unpredictable hydrolysis or secondary metabolite formation during cephalothin’s shelf life. Its manageable solubility and reconstitution speed earn marks from both pharmacists and veterinarians. With later molecules, even small formulation differences can lead to clogging, instability, or unpredictable tissue reactions—problems less frequent when using cephalothin shaped by long practice and direct user feedback.

    Where cephalothin stands apart is also in its predictability—once a process is validated, deviation rates drop, and both our teams and end users gain confidence. Routine does not mean complacency; product improvement continues. Batch-to-batch reproducibility forms the backbone of our cephalothin line, not just in chemical composition but in powder flow, packaging durability, and documentation support. Both new and long-standing clients often highlight this practical reliability over hypothetical improvements promised by next-generation molecules.

    Responding to New Challenges

    The role of cephalothin evolves with shifting needs. In several regions, pressure from resistance trends and updated guidelines sometimes reduces its routine use in clinical practice, but for research, reference standardization, and targeted veterinary interventions, requests for our product have held steady. Veterinary professionals and researchers return for cephalothin because it works, is predictable, and slots neatly into established protocols. Many have told us that their workflows depend on not needing to troubleshoot differences from batch to batch.

    Logistics have grown more complicated over the years, with increased regulation around antibiotics in transport and storage. We adapted by investing in better tracking systems and temperature controls along the chain. Our logistics and quality teams plan for shipping holds, customs delays, and facility audits. Nothing frustrates end users more than receiving delayed or degraded product, so we push to solve these bottlenecks before the product leaves our facility. Field experience has shown that quality management doesn’t end with batch release; it extends through delivery to how the material behaves when opened at the point of use.

    Sustaining Value Through Direct Experience

    Direct user feedback remains at the center of our improvements. Reports from research benches, veterinary clinics, and field applications often guide our process adjustments. Particulate load, moisture pickup, and sedimentation rates used to be recurring challenges—in response, we refined filtration systems, adjusted milling parameters, and overhauled packaging. Several partners reported improved syringeability and less clogging after these changes.

    Collaboration with veterinarians and research scientists allows us to anticipate and meet new needs: purity optimization for sensitive assays, micronization for novel delivery systems, and consistent documentation for increasingly strict audits. Our teams participate in technical conferences, share findings, and draw on decades of cephalothin production to inform best practices.

    Conclusion: Cephalothin’s Role Today

    Cephalothin remains more than a legacy molecule for us. Each batch reflects technical experience, detailed process controls, and feedback from clients shaping how we manufacture and supply this product. Differences from newer cephalosporins—focused spectrum, reliable handling, stabilization advantages—continue to benefit both veterinarians and researchers using the product in work that demands consistency and traceability. Our approach aims for more than compliance: Each improvement in process, packaging, and responsiveness strengthens the value cephalothin brings to healthcare, agricultural, and research settings. Years of production build confidence in the product and in our commitment to supporting those who rely on its unique properties.